Literature DB >> 18691079

Post traumatic lesion absence of beta-dystroglycan-immunopositivity in brain vessels coincides with the glial reaction and the immunoreactivity of vascular laminin.

Adrienn Szabó1, Mihály Kálmán.   

Abstract

Following brain lesions, the gliovascular basal lamina undergoes destruction and the gliovascular connections 'decouple'. Laminin receptors, as dystroglycan, are essential in these processes. The present study compares the immunoreactivities of beta-dystroglycan, glial fibrillary acidic protein (GFAP), and laminin following stab wounds in adult rats. In intact brain the vessels were immunopositive to beta-dystroglycan, whereas the laminin of their basal lamina proved to be unavailable to immunoreactions. Following stab wound, however, the adjacent vessels lost their immunopositvity to beta-dystroglycan, whereas immunopositivity to laminin became detectable in them. In an advanced stage of glial reaction the territory of GFAP immunopositive reactive astrocytes coincided with the area where vessels lost their immunopositivity to beta-dystroglycan. When glial reaction regressed, the beta-dystroglycan immunopositivity re-appeared, and laminin immunopositivity became undetectable again. Post-lesional disappearance of vascular beta-dystroglycan immunostaining was described earlier, and was attributed to the cleavage of beta-dystroglycan by matrix metalloproteinases as a mechanism of the decoupling of the gliovascular connections. Our results, which were obtained in a different type of lesion support that the loss of vascular beta-dystroglycan immunopositivity is a general phenomenon following cerebral lesions, and an indirect marker of gliovascular decoupling. For the first time coincidences were presented between vascular immunonegativity to beta-dystroglycan, glial reaction and detectability of laminin. Manifestation of laminin immunoreactivity also indicates gliovascular decoupling. Coincidence between glial reaction and lack of vascular beta-dystroglycan suggests mutual enhancement between them. The observations may have clinico-pathologic importance since similar investigations may help to follow the progression and regression of post-lesion processes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18691079     DOI: 10.2174/156720208785425657

Source DB:  PubMed          Journal:  Curr Neurovasc Res        ISSN: 1567-2026            Impact factor:   1.990


  6 in total

1.  Glial and perivascular structures in the subfornical organ: distinguishing the shell and core.

Authors:  Károly Pócsai; Mihály Kálmán
Journal:  J Histochem Cytochem       Date:  2015-02-11       Impact factor: 2.479

2.  Components of the basal lamina and dystrophin-dystroglycan complex in the neurointermediate lobe of rat pituitary gland: different localizations of beta-dystroglycan, dystrobrevins, alpha1-syntrophin, and aquaporin-4.

Authors:  Károly Pócsai; Zsolt Bagyura; Mihály Kálmán
Journal:  J Histochem Cytochem       Date:  2010-02-01       Impact factor: 2.479

3.  No rapid and demarcating astroglial reaction to stab wounds in Agama and Gecko lizards and the caiman Paleosuchus - it is confined to birds and mammals.

Authors:  Dávid Lőrincz; Mihály Kálmán
Journal:  Histol Histopathol       Date:  2020-10-27       Impact factor: 2.303

Review 4.  Pathophysiogenesis of mesial temporal lobe epilepsy: is prevention of damage antiepileptogenic?

Authors:  G Curia; C Lucchi; J Vinet; F Gualtieri; C Marinelli; A Torsello; L Costantino; G Biagini
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

5.  Appearance of β-dystroglycan precedes the formation of glio-vascular end-feet in developing rat brain.

Authors:  Mihály Kálmán; Erzsébet Oszwald; István Adorján
Journal:  Eur J Histochem       Date:  2018-05-18       Impact factor: 3.188

Review 6.  Novel therapeutic modulators of astrocytes for hydrocephalus.

Authors:  Yijian Yang; Chuansen Wang; Rui Chen; Yuchang Wang; Changwu Tan; Jingping Liu; Qinghua Zhang; Gelei Xiao
Journal:  Front Mol Neurosci       Date:  2022-09-26       Impact factor: 6.261

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.